基本信息
浏览量:4
职业迁徙
个人简介
Research Interests
Current treatment modalities remain to be optimized due to an insufficient understanding of disease etiology, variation in responses to existing therapeutic agents and drug-related problems from the use of concurrent drug therapies. It is thus my long term research goal to integrate my training in clinical pharmacy, molecular pharmacology and pharmacogenomics into a translational research platform that serves to optimize drug use through personalized medicine, medication therapy management and exploration of innovative drug regimens. In this regard, I’m interested in the following research areas:
Pharmacogenomics and clinical pharmacology
Identifying genetic variants that influence drug response and toxicity
Improving drug efficacy and safety of chemotherapeutic and psychoactive agents through therapeutic drug monitoring
Pharmacodynamics and molecular pharmacology
Understanding of molecular mechanisms of novel and investigational anticancer agents
Screening for effective combinations of anticancer drugs for both cancer treatment and metastasis reduction
Pharmacy practice research
Characterization of the efficacy and toxicity profiles of currently used medicines with an emphasis on oncology and neuropsychiatric medications
Understanding drug utilization through evaluating drug prescribing patterns in relation to current treatment guidelines and their influence on clinical outcomes
Current treatment modalities remain to be optimized due to an insufficient understanding of disease etiology, variation in responses to existing therapeutic agents and drug-related problems from the use of concurrent drug therapies. It is thus my long term research goal to integrate my training in clinical pharmacy, molecular pharmacology and pharmacogenomics into a translational research platform that serves to optimize drug use through personalized medicine, medication therapy management and exploration of innovative drug regimens. In this regard, I’m interested in the following research areas:
Pharmacogenomics and clinical pharmacology
Identifying genetic variants that influence drug response and toxicity
Improving drug efficacy and safety of chemotherapeutic and psychoactive agents through therapeutic drug monitoring
Pharmacodynamics and molecular pharmacology
Understanding of molecular mechanisms of novel and investigational anticancer agents
Screening for effective combinations of anticancer drugs for both cancer treatment and metastasis reduction
Pharmacy practice research
Characterization of the efficacy and toxicity profiles of currently used medicines with an emphasis on oncology and neuropsychiatric medications
Understanding drug utilization through evaluating drug prescribing patterns in relation to current treatment guidelines and their influence on clinical outcomes
研究兴趣
论文共 39 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Microfluidic Devices for Biomedical Applicationspp.261-327, (2021)
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2020): S116-S116
引用0浏览0引用
0
0
Phase I Oncology Drug Developmentpp.119-138, (2020)
Elements (2020)
引用0浏览0引用
0
0
引用23浏览0引用
23
0
Victoria Haldane,Yao Guo Tan,Krichelle Wei Qi Teo,Joel Jun Kai Koh, Aastha Srivastava, Rui Xiang Cheng, Yi Cheng Yap,Pei-Shi Ong,Rob M. Van Dam, Jie Min Foo,Falk Mueller-Riemenschneider,Gerald Choon-Huat Koh,
Victoria Haldane,Joel Jun Kai Koh, Aastha Srivastava,Krichelle Teo,Yao Guo Tan, Rui Xiang Cheng, Yi Cheng Yap,Pei Shi Ong,Rob Martinus Van Dam, Jie Min Foo,Falk Müller-Riemenschneider,Gerald Choon Huat Koh,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn